Clinicopathological features of antineutrophil cytoplasmic antibodies-associated vasculitis in Japanese patients with IgA nephropathy

被引:0
|
作者
Shimizu M. [1 ]
Wada T. [1 ]
Sakai N. [1 ]
Izumiya Y. [1 ]
Furuichi K. [1 ]
Misaki T. [1 ]
Kobayashi K. [1 ,2 ]
Goshima S. [3 ]
Takeda S. [4 ]
Yokoyama H. [1 ,2 ]
机构
[1] First Department of Internal Medicine, School of Medicine, Kanazawa University, 13-1 Takara-machi, Kanazawa
[2] Division of Blood Purification, Kanazawa University Hospital, Kanazawa
[3] Department of Internal Medicine, Inami General Hospital, Inami
[4] Department of Internal Medicine, Kurobe City Hospital, Kurobe
关键词
Antineutrophil cytoplasmic antibodies; Crescentic glomerulonephritis; Immunoglobulin A nephropathy; Immunosuppressive therapy;
D O I
10.1007/s101570070030
中图分类号
学科分类号
摘要
Antineutrophil cytoplasmic antibodies (ANCA) have been reported to be associated with systemic vasculitis. However, the roles of ANCA subtypes in patients with IgA nephropathy remain to be fully investigated. We describe three Japanese patients with IgA nephropathy complicated by ANCA-associated vasculitis. Two patients with IgG class ANCA developed rapidly progressive renal failure and demonstrated mesangial proliferation with extensive extracapillary proliferation and segmental glomerular necrosis. One patient with IgM class ANCA showed severe extrarenal symptoms, such as lung fibrosis and neuritis, in addition to glomerular crescent formation. All three patients received immunosuppressive therapies, including corticosteroids and cyclophosphamide. The two patients who received these treatments early showed improvement in urinary protein excretion and renal function, in accordance with a decrease in the serum titer of ANCA. However, one patient in whom serum creatinine was already elevated showed a poor response to the treatment. These results suggest that ANCA subtypes may participate in the pathogenesis of crescent formation in patients with IgA nephropathy, and that early treatment with a combination of methylprednisolone pulse therapy, oral prednisolone, and cyclophosphamide pulse therapy may be beneficial in these patients.
引用
收藏
页码:251 / 256
页数:5
相关论文
共 50 条
  • [1] Nitrofurantoin Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis
    Ubaid, Aamer
    Waheed, Farishta
    Naeem, Awais
    AMERICAN JOURNAL OF THERAPEUTICS, 2020, 27 (06) : E688 - E689
  • [2] Propylthiouracil induced antineutrophil cytoplasmic antibodies-associated vasculitis
    LIU Hui-lin
    GAO Mei-juan
    ZHENG Ya-an
    LIU Gui-hua
    中华医学杂志(英文版), 2013, 126 (24) : 4814 - 4814
  • [3] Propylthiouracil induced antineutrophil cytoplasmic antibodies-associated vasculitis
    Liu Hui-lin
    Gao Mei-juan
    Zheng Ya-an
    Liu Gui-hua
    CHINESE MEDICAL JOURNAL, 2013, 126 (24) : 4814 - 4814
  • [4] Is Rituximab "The Wonder Drug" for Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis?
    Jha, Saket
    Naidu, G. S. R. S. N. K.
    Sharma, Aman
    INDIAN JOURNAL OF RHEUMATOLOGY, 2019, 14 (01) : 4 - 6
  • [5] Trimethoprim-sulfamethoxazole and antineutrophil cytoplasmic antibodies-associated vasculitis
    Tervaert, Jan Willem Cohen
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (04) : 388 - 394
  • [6] Increased Prevalence of Thyroid Disease in Patients with Antineutrophil Cytoplasmic Antibodies-associated Vasculitis
    Prendecki, Maria
    Martin, Leyre
    Tanna, Anisha
    Antonelou, Marilina
    Pusey, Charles D.
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (05) : 686 - 689
  • [7] Clinical features of two cases of deafness related to antineutrophil cytoplasmic antibodies-associated vasculitis
    Igarashi, S.
    Otani, T.
    Takahashi, Y. K.
    Soga, K.
    Irioka, T.
    Yokota, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 541 - 541
  • [8] Chemokines and Cytokines Profiles in Patients with Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis: A Preliminary Study
    Daca, Agnieszka
    Storoniak, Hanna
    Debska-Slizien, Alicja
    Kusztal, Mariusz Andrzej
    Krajewska, Magdalena
    Lisowska, Katarzyna Aleksandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [9] Central Nervous System Disease in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis
    Graf, Jonathan
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2017, 43 (04) : 573 - +
  • [10] Acute respiratory failure as primary manifestation of antineutrophil cytoplasmic antibodies-associated vasculitis
    Sourla, Evdokia
    Bagalas, Vasilis
    Tsioulis, Helias
    Paspala, Asimina
    Akritidou, Sofia
    Pataka, Athanasia
    Fekete, Katalin
    Kioumis, Loannis P.
    Stanopoulos, Loannis
    Pitsiou, Georgia
    CLINICS AND PRACTICE, 2014, 4 (02) : 27 - 29